Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
Led by researchers at the Vanderbilt University Medical Center, a new study reports that Optellum's FDA-cleared Lung Cancer Prediction (LCP) AI assisted risk stratification for indeterminate lung nodules is cost-effective from a US payer perspective. Optellum's LCP AI supports more consistent long nodule management and helps enable earlier diagnosis of...
The partnership combines Electrome's programmable, AI-driven bioelectric platform with BIEL's FDA-cleared devices and extensive clinical track record, establishing a scalable foundation for the delivery of non-pharmacologic therapies across clinical and consumer markets
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
The RPD Pilot trial builds on the strong results from Verve’s TUSK feasibility trial, which demonstrated an average reduction of approximately 20 mmHg in systolic blood pressure among treated patients through one year of follow-up
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
This strategic move unites Fertio’s 20+ years of global expertise with Cascade’s innovative early donor disclosure program, advancing fertility care and family-building options for U.S. parents
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’

Transaction will expand VB Spine’s enhanced visualization portfolio to include augmented reality navigation with the Augmedics xvision Spine System®

The VitalsBridge products are acquired from Dynasthetics, based in Salt Lake City, Utah. The company is well known for creating and producing simulation, anaesthesia, and respiratory products.
The funding will accelerate Earendil Labs’ AI-driven R&D platform, expand its interdisciplinary teams, and advance a growing pipeline of antibody and biologics programs, with the goal of delivering first-in-class and best-in-class therapies for patients with serious diseases.
Financing co-led by Taiho Ventures and Arkin Bio Capital with significant participation from other new and existing investors
By Dinesh Kumar, Ph.D., Founder and CEO of Blend Health Technologies

The CellTolerance® Test ends years of trial-and-error diets by pinpointing food intolerances through live cellular imaging

Even small declines in measles vaccination coverage costs the United States billions, revealing why prevention infrastructure matters more than emergency response
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfunction
Dr. Debra Barker, Chief Medical Officer, Centauri Therapeutics, said: “This designation from the FDA will be invaluable as we continue to advance toward first in-human trials for CTX-187. The recognition of the potential value of our technology further underpins our belief in its potential to transform treatment paradigms for Gram-negative bacterial infections, filling an urgently needed gap in the market for new and effective treatment options for clinically vulnerable patients.”
Orthopedic industry veteran to lead U.S. commercial expansion and accelerate adoption of EnFix® demineralized bone fiber implants for bone-tendon healing in Sports Medicine and Foot and Ankle
“We are pleased to be able to bring Dr. Khan into our leadership team. He brings a strong blend of clinical, scientific, and strategic insight to SynerFuse® that will help us in our mission to provide relief to people afflicted with chronic low back and leg pain,” said SynerFuse® CEO and Founder Justin Zenanko.
Bioprocessing leader to drive continued commercial development and international expansion

By simplifying complex cardiac anatomy through real-time AI labeling, T-Mode™ Heart removes the training barrier to ultrasound adoption for family physicians and medical students

Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows

CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day to support faster diagnosis by making scans available in near-real time
Chief People Officer, Nikki Romence, has been named one of Becker’s Hospital Review’s “140 Hospital and Health System CHROs and Chief People Officers to Know” for 2026
Located in southeast Jacksonville near Baptist Medical Center Clay, the multispecialty ASC supports procedures in orthopedics, urology, otolaryngology, pain management, and general surgery. With 15 physician partners committed to the center, the partnership is evaluating expansion opportunities to meet growing demand.
The clinic is currently conducting research into single-fraction treatment, where therapy is delivered in one session (while traditional radiotherapy requires 20–40 treatment sessions)
Teams delivering minimally invasive care face radiation exposure and orthopedic injuries that could be reduced through new policies and modern technology
The research focused on patients with stage T1a renal cell carcinoma, a cancer that is increasingly found incidentally on CT scans performed for other reasons, such as imaging of the prostate or ovaries
$3 million investment strengthens foundation for the next generation of military family support

Creating a healthier indoor workplace is not a single project — it is an ongoing commitment to the people who spend their working hours inside your building.

Swypes is calling attention to a critical gap in healthcare hygiene: although hospitals and nursing homes enforce strict infection-control protocols, CDC figures and published research suggest mobile phones remain an overlooked risk in daily care settings, with one meta-analysis finding contamination on 84.5% of healthcare workers’ devices

Choosing the right partner to build a digital health product is a high-stakes decision that goes far beyond checking boxes on a list of technical requirements
TransDental is a dedicated dental billing company serving independent practices and group offices across the United States
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.